Geptanolimab (CBT-501) is a humanized IgG4 kappa monoclonal antibody that targets the programmed death-1 (PD-1) receptor. This antibody functions by competitively inhibiting the interaction between PD-1 and its ligands PD-L1 and PD-L2, thereby modulating immune responses. Geptanolimab is primarily utilized in cancer research to investigate the therapeutic potential of PD-1 blockade in oncology.
Geptanolimab (CBT-501) is a humanized IgG4 kappa monoclonal antibody that targets the programmed death-1 (PD-1) receptor. This antibody functions by competitively inhibiting the interaction between PD-1 and its ligands PD-L1 and PD-L2, thereby modulating immune responses. Geptanolimab is primarily utilized in cancer research to investigate the therapeutic potential of PD-1 blockade in oncology.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
